Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 11
- −2 vs. Q1 2024
- Portfolio value
- $795.8M
- +$15.9M (+2.0%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 1,146,979 | $624.2M | 78.4% | +172,338+17.7% | Added | History |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $135.3M | 17.0% | 00.0% | Unchanged | – |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $9.05M | 1.1% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $7.00M | 0.9% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $5.94M | 0.7% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $4.26M | 0.5% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $4.01M | 0.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $3.15M | 0.4% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 657,899 | $2.01M | 0.3% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $960.3K | 0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $2.84K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q1 2024 (2)
Positions held at the end of Q1 2024 that are gone from this filing.